These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1950539)

  • 1. Kinetic profile of miocamycin in middle ear fluid and mucosa.
    Fraschini F; Scaglione F; Falchi M; Nebuloni R; Zampella K; Saudelli M; De Luca M; Casini A; Pintucci GP
    Acta Otolaryngol; 1991; 111(4):756-61. PubMed ID: 1950539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miocamycin distribution in tonsillar and pulmonary tissues after repeated administration.
    Scaglione F; Falchi M; Nebuloni R; Cattaneo G; Pintucci JP; Mezzetti M; Zampella K; Saudelli M; Casini A; Fraschini F
    J Chemother; 1990 Dec; 2(6):384-9. PubMed ID: 2093111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some pharmacokinetic data on miocamycin II. Concentrations in gynaecological tissues.
    Furneri PM; Cianci A; Garozzo A; Roccasalva L; Pinizzotto MR; Palumbo G; Tempera G
    Drugs Exp Clin Res; 1991; 17(3):181-5. PubMed ID: 1914845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media.
    Edén T; Anari M; Ernstson S; Sundberg L
    Scand J Infect Dis Suppl; 1983; 39():48-52. PubMed ID: 6580733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
    Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
    J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic and biochemical study of vascular permeability of the middle ear mucosa in experimental otitis media.
    Sakagami M; Harada T; Juhn SK; Duvall AJ
    Ann Otol Rhinol Laryngol; 1990 Aug; 99(8):654-9. PubMed ID: 1696441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of substance P upon middle ear effusion of secretory otitis media and the mode of action].
    Huang W; Jiang H; Qiu J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Jun; 11(6):249-51. PubMed ID: 9812802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mucous cell metaplasia in the middle ear of rats using a three-step method: an improved model for otitis media with mucoid effusion.
    Tsuboi Y; Kim Y; Giebink GS; Le C; Paparella MM; Chen N; Schachern PA; Juhn SK; Lin J
    Acta Otolaryngol; 2002 Mar; 122(2):153-60. PubMed ID: 11936906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells and histamine in adenoid tissue and middle ear.
    Palva T; Taskinen E; Lehtinen T; Ramsay H; Björksten F; Hackman P
    Acta Otolaryngol; 1991; 111(2):349-53. PubMed ID: 1712531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serous otitis media and immunological reactions in the middle ear mucosa.
    van der Baan S; Seldenrijk CA; Henzen-Logmans SC; Drexhage HA
    Acta Otolaryngol; 1988; 106(5-6):428-34. PubMed ID: 3061276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of enoxacin into middle ear effusion.
    Sundberg L; Edén T
    Acta Otolaryngol; 1990; 109(5-6):438-43. PubMed ID: 2360450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between the content of fibrinogen in middle ear effusion and the effect of treatment on secretory otitis media].
    Chen XH; Wu X; Huang B
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Aug; 41(8):566-9. PubMed ID: 17039794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microbiome of otitis media with effusion in Indigenous Australian children.
    Jervis-Bardy J; Rogers GB; Morris PS; Smith-Vaughan HC; Nosworthy E; Leong LE; Smith RJ; Weyrich LS; De Haan J; Carney AS; Leach AJ; O'Leary S; Marsh RL
    Int J Pediatr Otorhinolaryngol; 2015 Sep; 79(9):1548-55. PubMed ID: 26228497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PO2 levels in middle ear effusions and middle ear mucosa.
    Takahashi M; Niwa H; Yanagita N
    Acta Otolaryngol Suppl; 1990; 471():39-42. PubMed ID: 2239244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.
    Krause PJ; Owens NJ; Nightingale CH; Klimek JJ; Lehmann WB; Quintiliani R
    J Infect Dis; 1982 Jun; 145(6):815-21. PubMed ID: 7200999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compositional difference in middle ear effusion: mucous versus serous.
    Chung MH; Choi JY; Lee WS; Kim HN; Yoon JH
    Laryngoscope; 2002 Jan; 112(1):152-5. PubMed ID: 11802055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [pH of fluid collected from middle ear in the course of otitis media in children].
    Wezyk MT; Makowski A
    Otolaryngol Pol; 2000; 54(2):131-3. PubMed ID: 10961068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of IFN-gamma measurement in middle ear effusion of secretory otitis media].
    Chen S; Liang X; Zheng Y; Liu W; Liu X; Long H; Zheng P
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(13):590-2. PubMed ID: 16200827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of complements in serum and middle ear effusion of the patients with secretory otitis media].
    Sun W; Liu Z; Sun Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Feb; 11(2):59-60. PubMed ID: 9644181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.